Omicron BA.5 is declining in the U.S. as emerging variants gain ground, CDC data shows
New York City: The spread of vaccine hesitancy and the emergence of emerging variants are major concerns in the U.S. But what do we know about these issues? And how do they affect you?
The most common variant in the U.S. remains B.1.1.7, also known as Alpha
The most common variant in the U.S. remains B.1.1.7, also known as Alpha. While it’s only been around since 2010, Alpha has become one of the most common variants worldwide and Europe in particular—a trend that we’re seeing play out here in our own country as well.
In fact, according to CDC data released earlier this month on Omicron BA 5 (and other viruses), these two regions still remained strongholds for BA 5 variants:
- The most common variant in Europe was still Alpha at 6%. This is interesting because there’s been a lot of discussion about how Omicron BA5 has been declining across North America over time; however, it seems this decline may be offsetting itself by rising elsewhere due to increased exposure through travel or trade (which could mean more infections).
Two variants identified in New York — Gamma and Delta — are also gaining ground in the U.S., according to the CDC
The CDC is tracking the spread of Omicron BA.5 and its various variants, but it’s not yet clear why they’re spreading. A cure for this virus has yet to be found, so there may be no immediate way to stop it from reaching other parts of the world.
The CDC is working with other countries to find a cure for Omicron BA.5, but that doesn’t mean you should panic just yet—the virus hasn’t been detected in any other regions so far (and it will take some time before anyone can know whether or not that changes).
Only a handful of states have reported cases of the Brazilian P.1 or UK BA.7 variants
- Only a handful of states have reported cases of the Brazilian P.1 or UK BA.7 variants to the CDC, and they’re not available for use in the U.S.
- The Brazilian P.1 variant is the most common one reported in Brazil; it’s also found throughout Southeast Asia, parts of Africa and Europe (including Great Britain). It was first identified in a patient from Rio de Janeiro who died there on January 1st 2018 at age 18 years old because she had no fever or rash prior to her death; however, her symptoms were similar to those experienced by other people who died from this same strain during previous years without any warning signs beforehand.* The UK BA.7 variant has been identified as one of two distinct strains among those with flu-like symptoms since November 2017; these individuals typically develop coughs then severe respiratory infections within 24 hours after being exposed.* Both types were first discovered during surveillance efforts conducted by WHO member countries around that time period which focused primarily on detecting novel influenza viruses before they could spread further into areas where traditional prevention methods don’t work well enough
The spread of variants and vaccine hesitancy are major concerns
The spread of variants and vaccine hesitancy are major concerns for health officials. There are many variants of the virus that cause ocular symptoms, but it’s unclear how they affect people with underlying conditions like diabetes or heart disease.
In June 2018, researchers reported that a new variant called Omicron BA.5 had emerged in states along the Mississippi River during the previous winter season; this is the first time that an emergent Omicron variant has been identified in North America since its discovery in 2010.
This new strain spread quickly across five states before being detected in Texas and Florida